Rong Jiang

Title: Innovations in Biomarker Research: The Contributions of Rong Jiang

Introduction

Rong Jiang is an accomplished inventor based in Pleasanton, CA, known for his significant contributions to the field of biomarker research. With a focus on complex multi-factorial disorders such as cancer, his work has the potential to revolutionize diagnostic methods and patient surveillance.

Latest Patents

Rong Jiang holds a patent for "Circulating miRNA biomarker signatures." This patent outlines methods for diagnosing and monitoring complex disorders by screening easily accessible biomarkers. His research has identified highly stable cell-free Circulating Nucleic Acids (CNA) present in human blood and plasma. The correlations between tumor-associated genomic, epigenetic, and transcriptional changes, along with alterations in CNA levels, serve as strong predictors for the clinical utility of this biomarker class. The patent also details methods for using microRNAs (miRNAs) as markers that can link specific expression profiles to cancer development. Additionally, it includes techniques for isolating plasma fractions to study miRNA biomarkers and measure circulating miRNA levels.

Career Highlights

Throughout his career, Rong Jiang has worked with notable companies such as Affymetrix, Inc. and Genisphere, LLC. His experience in these organizations has contributed to his expertise in biomarker research and development.

Collaborations

Rong Jiang has collaborated with esteemed colleagues, including Radharani Duttagupta and Keith W. Jones. These partnerships have further enhanced his research and innovation in the field.

Conclusion

Rong Jiang's work in biomarker research exemplifies the intersection of innovation and healthcare. His patent on circulating miRNA biomarkers represents a significant advancement in the diagnosis and surveillance of complex disorders. The implications of his research could lead to improved clinical outcomes for patients facing multifactorial diseases.